You are viewing a historical snapshot of United States (NYSE / Nasdaq). These figures are a preview to show what TradeTidings covers. Live, continuously updated United States sentiment and stock impact is a Pro feature.
Get live United States data with ProPfizer (PFE)
5 stories published on PFE since July 2026. See all coverage.
News sentiment trend
Counts of positive, neutral, and negative news items over the last 90 days. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Sentiment timeline
How news sentiment on Pfizer (PFE) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
Why this reading
The recent items weighing most on this reading, by direction and influence.
Pfizer Stock: FDA Approves PADCEV Plus Keytruda for Early Bladder Cancer
Direct news · Medium influence · Long term
Pfizer's Old Headquarters Decays as Its Stock Lags for Years
Direct news · Medium influence · Long term
Pfizer Wins FDA Approval for Ibrance in HER2 Positive Breast Cancer
Direct news · Medium influence · Long term
Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Drug Efficacy
Direct news · Low influence · Long term
Sanofi Sues Pfizer and Moderna Over mRNA Vaccine Patents
Direct news · Low influence · Long term
Direct news
The most recent stories naming PFE directly, across all of our coverage.
Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Drug Efficacy
Sanofi Sues Pfizer and Moderna Over mRNA Vaccine Patents
Pfizer Stock: FDA Approves PADCEV Plus Keytruda for Early Bladder Cancer
Pfizer's Old Headquarters Decays as Its Stock Lags for Years
Pfizer Wins FDA Approval for Ibrance in HER2 Positive Breast Cancer
Indirect drivers in the news
Macro, commodity, FX and regulatory forces that have moved PFE, with the stories behind each.
No indirect-driver news for PFE in our coverage yet.
Also monitored for PFE (no news in our coverage yet): FDA approvals & trial outcomes, Drug pricing / FDA / IRA.
See the full picture
Sign up free to track PFE, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track PFE for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.